Number of Patients Included in Analyses of GST Genotypes in Patients With ALL by SJCRH Treatment Protocol
| Analysis . | Total n . | Total X . | Total XI . | Total XII . | Total XIIIA . | Total XIIIB . | Not Treated on a Total Protocol . |
|---|---|---|---|---|---|---|---|
| Outcome in those with DNA sample v those without; and GST as a predictor of outcome | 161 with DNA | 0 | |||||
| 525 without DNA | |||||||
| 0 | 61 | ||||||
| 280 | 75 | ||||||
| 107 | 25 | ||||||
| 138 | 0 | ||||||
| 0 | 0 | ||||||
| 0 | |||||||
| GST genotype in ALL v controls | 197 ALL | 4 | 61 | 75 | 25 | 27 | 5 |
| Predictors of double-null genotype among patients with ALL | 192 ALL | 4 | 61 | 75 | 25 | 27 | 0 |
| Analysis . | Total n . | Total X . | Total XI . | Total XII . | Total XIIIA . | Total XIIIB . | Not Treated on a Total Protocol . |
|---|---|---|---|---|---|---|---|
| Outcome in those with DNA sample v those without; and GST as a predictor of outcome | 161 with DNA | 0 | |||||
| 525 without DNA | |||||||
| 0 | 61 | ||||||
| 280 | 75 | ||||||
| 107 | 25 | ||||||
| 138 | 0 | ||||||
| 0 | 0 | ||||||
| 0 | |||||||
| GST genotype in ALL v controls | 197 ALL | 4 | 61 | 75 | 25 | 27 | 5 |
| Predictors of double-null genotype among patients with ALL | 192 ALL | 4 | 61 | 75 | 25 | 27 | 0 |